Author

Swetlana Mukherjee

Observed name: Swetlana Mukherjee Indraprastha

Institution: Indraprastha Apollo Hospitals

Observed institution: Indraprastha Apollo Hospitals

ORCID: 0000-0002-8959-9691

Observed ORCID: 0000-0002-8959-9691

OpenAlex ID: A5083692121

Shifting paradigms from myeloablation to immune modulation: pre-transplant immune-suppression and post-transplant cyclophosphamide in human leucocyte antigen identical related donor hematopoietic stem cell transplantation for sickle cell disease

2026 · Gaurav Kharya, Garima Nirmal, et al. · Haematologica · 1

Improving Bone Density and Alleviating Pain with Denosumab in Thalassemia Patients with Osteoporosis: Evidence from an Interventional Study

2026 · Sneha Bhosle, Swetlana Mukherjee, et al. · Indian Journal of Hematology and Blood Transfusion · 1

Exploring Denosumab for osteoporosis in patients with transfusion-dependent thalassemia

2024 · Sneha Bhosle, Amita Mahajan, et al. · Pediatric Hematology Oncology Journal

Osteoporosis in transfusion-dependent thalassemia: A major contributor to morbidity

2024 · Sneha Bhosle, Amita Mahajan, et al. · Pediatric Hematology Oncology Journal

Exploring Denosumab for osteoporosis in patients with transfusion-dependent thalassemia

2024 · Sneha Bhosle, Amita Mahajan, et al. · Pediatric Hematology Oncology Journal

Time to antibiotic administration (TTA) and its impact on outcome: A single center retrospective study on children with febrile neutropenia

2023 · Shreyasi Das, Swetlana Mukherjee, et al. · Pediatric Hematology Oncology Journal

Clinical profile and outcome of impact of minimal residual assessment on outcomes in a cohort of patients with acute lymphoblastic leukemia

2022 · Shreyasi Das, Swetlana Mukherjee, et al. · Pediatric Hematology Oncology Journal

Outcomes for childhood acute lymphoblastic leukemia stratified for age: Age is not just a number!

2022 · Swetlana Mukherjee, Shreyasi Das, et al. · Pediatric Hematology Oncology Journal

Works count: 8

Citation count: 2

H-index: 1

I10-index: